4basebio Balance Sheet Health
Financial Health criteria checks 1/6
4basebio has a total shareholder equity of £3.4M and total debt of £6.9M, which brings its debt-to-equity ratio to 201.5%. Its total assets and total liabilities are £11.6M and £8.1M respectively.
Key information
201.5%
Debt to equity ratio
UK£6.87m
Debt
Interest coverage ratio | n/a |
Cash | UK£3.56m |
Equity | UK£3.41m |
Total liabilities | UK£8.15m |
Total assets | UK£11.56m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4BB's short term assets (£5.1M) exceed its short term liabilities (£1.5M).
Long Term Liabilities: 4BB's short term assets (£5.1M) do not cover its long term liabilities (£6.7M).
Debt to Equity History and Analysis
Debt Level: 4BB's net debt to equity ratio (97.2%) is considered high.
Reducing Debt: Insufficient data to determine if 4BB's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4BB has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4BB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.